Skip to main content
main-content
Top

25-06-2017 | PD-1/PD-L1 inhibitors | Article

Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors

Judd J et al. Oncologist 2017; 22(10): 1232-1237. doi:10.1634/theoncologist.2017-0133

Please log in to get access to this content

Related topics